Epidermal growth factor and bombesin act synergistically to support intestinal adaptation in rats with massive small bowel resection

Abstract

Intestinal adaptation is the most important event in short bowel syndrome following a massive small bowel resection. Effects of various growth factors and their synergism have been well documented in intestinal adaptation. This study aimed to compare the effect of two different trophic agents, epidermal growth factor (EGF) and bombesin (BBS), on intestinal adaptation following massive intestinal resection. Sprague-Dawley male rats were assigned to one of four groups after a 75% small bowel resection. Either EGF (90 microg/kg), BBS (10 microg/kg), EGF+BBS, or bovine serum albumin (BSA) were injected subcutaneously three times a day. The animals were killed 10 days after the operation. Weight loss and morphologic parameters such as mucosal thickness, villus height, crypt depth, villus-to-crypt ratio, and muscularis propria height were measured. In the EGF+BBS group, mucosal thickness was found to be significantly increased compared with the other study groups (p<0.05). Similarly, villus height was significantly increased only in the EGF+BBS group (p<0.05). In the BBS group, both villus height and mucosal thickness showed a slight increase, but the values were not statistically significant compared with the vehicle-treated group. There were no significant differences in any of the remaining parameters between the groups. The results of this study indicate that the gut hormones EGF and BBS act synergistically in facilitating the adaptive response of the remnant ileum to massive intestinal resection.

Kampo Medicine “Dai-Kenchu-To” Prevents Bacterial Translocation in Rats

“…Villous height was measured by micrometry using a microscope; at least five measurements from nonoverlapping well-oriented areas were taken from each sample and results expressed in micrometers. The villous height was defined as the micrometry from the base of the villus to the tip [25,26].…”

Short-Bowel Syndrome in Children — An Update in Management Strategies

“…Possible mechanisms of action include a reduction in apoptosis of intestinal cells, increased expression of the anti-apoptotic gene bcl-w, and decreased expression of the pro-apoptotic gene bax [75]. Several authors have investigated the synergistic role of EGF in experimental studies along with other factors such as interleukin-11, bombesin and neurotensin, and found that they further enhance the adaptive action of EGF [76][77][78]. Promising results with the use of EGF were reported in a pilot study by Sigalet et al [79] who investigated the effect of enterally administered recombined EGF on nutrient absorption and tolerance feeding in infants with severe PSBS (<25% bowel length for predicting age).…”

Kampo medicine “Dai-kenchu-to” prevents CPT-11-induced small-intestinal injury in rats

“…Villous height was measured by micrometry using a microscope: At least five measurements from no overlapping well-oriented areas were taken from each sample and results expressed in micrometers. The villous height was defined as the micrometry from the base of the villous to the top [15,16]. All assessments were conducted in a blinded fashion.…”